AzTrials
AzTrials

Alcohol Use, UnspecifiedNCT06401967

Study of a Smartphone-Based Alcohol Reduction Program

A study testing Pivot Clear and BACtrack breathalyzer in people with Alcohol Use, Unspecified, run by Pivot Health Technologies Inc. at 1 site in United States.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

Prospective, open label, single center clinical study enrolling up to 100 adult participants to evaluate the feasibility, acceptability, and preliminary outcomes of the Pivot Clear smartphone-based alcohol reduction program. Read more about this study

Who is it for?
Ages 21 years and olderHealthy volunteers can take part
Conditions the study is for
Alcohol Use, Unspecified
What is being tested?
Pivot Clear and BACtrack breathalyzer
Could I receive a placebo?
No, everyone receives an active treatment
How many people
0 participants
Where
1 siteUnited States
Study dates
Jun 2024to Jun 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Score of ≥ 3 for women and ≥ 4 for men on the AUDIT-C at screening
  • Would like to reduce or eliminate alcohol consumption
  • Resident of the United States
  • Able to read and comprehend English
  • Owns and uses a smartphone compatible with the study app (iPhone 6 and above, operating system iOS (iPhone operating system) 15 and above, or Android 7.0 and above, operating system Android 7.0 and above)
  • Has daily internet access on smartphone
Show all 9Show fewer
  • Comfortable downloading and using smartphone apps
  • Interested in working with an alcohol reduction coach via SMS text
  • Willing to sign the Informed Consent Form (ICF)

Who cannot join

  • Currently using other support to reduce or quit alcohol, including apps, coaching, support groups, classes or quit programs
  • Pregnant (self-reported)
  • Self-reported past or present diagnosis of Alcohol Use Disorder (AUD)
  • Self-reported past or present diagnosis of Substance Use Disorder
  • Current use of the following medications: suboxone, methadone, or daily use of a benzodiazepine [including Alprazolam (e.g., Xanax), lorazepam (e.g., Ativan), clonazepam (e.g., Klonopin), diazepam (e.g., Valium), and temazepam (e.g., Restoril)]
  • History of hospitalization or in-patient treatment due to alcohol use
Show all 9Show fewer
  • Using other alcohol reduction or abstinence apps, coaching, support groups, classes, or programs at study entry
  • Failure to provide contact or collateral information, and/or failure to verify email address
  • Participation in a previous study sponsored by Pivot Health Technologies, Inc. (formerly Carrot Inc.)

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Pivot Health Technologies, Inc.

    San Carlos, California, 94070

Other trials in United States

About this study

Official title: Feasibility, Acceptability, and Preliminary Outcomes of a Smartphone-Based Program for Reduction in Alcohol Consumption

Prospective, open label, single center clinical study enrolling up to 100 adult participants to evaluate the feasibility, acceptability, and preliminary outcomes of the Pivot Clear smartphone-based alcohol reduction program.

Read the detailed description

This is a prospective, open label, single center clinical study conducted with institutional review board (IRB) approval enrolling up to 100 adult participants who report at-risk alcohol consumption behavior and would like to reduce or eliminate alcohol consumption. The study will be performed remotely on an ambulatory basis. Participants will be asked to set up and use the Pivot Clear program. The program includes an app, personal breathalyzer, and short message service (SMS) text-based coaching with an alcohol reduction specialist. The study duration is 52 weeks. While participants will have access to the program for 52 weeks, it is expected that for most participants, most active participation in the program will be complete by 12 weeks. The primary reporting time point will be 12 weeks, with expected passive, longer-term follow-up outcomes collected at 26 weeks and 52 weeks. Participants will receive online questionnaires at intervals throughout the study (baseline, weekly for the first 12 weeks, at 26 weeks and at 52 weeks).

Being tested
Pivot Clear, BACtrack breathalyzer
Keywords
alcohol reduction, digital health, mobile apps, health promotion
Medical subject headings
Alcohol Drinking

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Pivot ClearBehavioural

    A mobile app and program for alcohol reduction.

  • BACtrack breathalyzerDevice

    Personal breathalyzer device that measures blood alcohol content.

Study groups in NCT06401967
Study groupRoleWhat they receive
Pivot ClearExperimentalA program for alcohol reduction
Receives: Behavioral: Pivot Clear; Device: BACtrack breathalyzer

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Proportion of participants who complete all 12 weekly follow-up assessments

    Calculated as the number of participants who complete 12/12 of the weekly follow-up assessments (specifically during the first 12 weeks of the study), divided by the total number of enrolled participants.

    Measured: 12 weeks

Secondary outcomes (50)
  1. Trial feasibility - enrollment

    Trial feasibility is assessed with multiple measures of enrollment success; all are the percentage of potential participants that remain eligible after each pre-enrollment step.

    1. The percent of potential participants who complete the online screening that are eligible for participation.
    2. The percent of potential participants who complete the eligibility phone call that are eligible for participation.
    3. The percent of potential participants who remain eligible after the screening call who consent and complete study enrollment (study enrollment includes: electronically signing the informed consent form, completing the baseline questionnaire, and completing registration in the app).

    Measured: Baseline

  2. Trial feasibility - questionnaire completion

    Trial feasibility is assessed with measuring the percent of enrolled participants who complete at least 80% of all study questionnaires.

    Measured: 52 weeks

  3. Average weekly alcohol consumption

    Reported as the mean number of standard drinks per week over the past 7-28 days, based on the timeline follow-back (TLFB) calendar method.

    Measured: 1-12, 26, and 52 weeks

  4. Proportion of participants with average drinks per day ≤ 2/day for men and ≤ 1/day for women

    Based on the average weekly alcohol consumption which is reported as the mean number of standard drinks per week over the past 7-28 days, based on the timeline follow-back (TLFB) calendar method.

    Calculated as the number of participants with average drinks per day ≤ 2/day for men and ≤ 1/day for women over the specified time period, divided by the total number of enrolled participants.

    Measured: 1-12, 26, and 52 weeks

  5. Proportion of participants who complied with the low-risk guideline for problematic drinking

    The low-risk guideline for problematic drinking is defined as having consumed no more than 7 drinks per week and no more than 3 drinks on any single day (for women), or 14 drinks per week and no more than 4 drinks on any single day (for men).

    Based on the average weekly alcohol consumption which is reported as the mean number of standard drinks per week over the past 7-28 days, based on the timeline follow-back (TLFB) calendar method.

    Calculated as the number of participants meeting the above low-risk guideline criteria over the specified time period, divided by the total number of enrolled participants.

    Measured: 1-12, 26, and 52 weeks

  6. Average daily alcohol consumption

    Reported as the mean number of standard drinks per day over the past 7-28 days, based on the timeline follow-back (TLFB) calendar method.

    Measured: 1-12, 26, and 52 weeks

  7. Average drinks per drinking day

    Reported as the mean number of standard drinks per drinking day (excluding days where no drinks were consumed) over the past 7-28 days, based on the timeline follow-back (TLFB) calendar method.

    Measured: 1-12, 26, and 52 weeks

  8. Proportion of participants with an AUDIT-C score below the threshold for unhealthy alcohol use in the U.S.

    AUDIT-C = Alcohol Use Disorders Identification Test-Consumption (the first three questions from the 10-item AUDIT, a tool developed by the World Health Organization to evaluate a person's use of alcohol).

    AUDIT-C scores range from 0 to 12 points, and are a sum of scores for each of its 3 questions. Lower scores indicate less alcohol use; higher scores indicate greater alcohol use. Unhealthy alcohol use in the U.S. is defined as a score greater than 4 for men, and a score greater than 3 for women.

    The number of individuals that have AUDIT-C scores below these thresholds will be divided by the total number of participants to obtain this outcome proportion.

    Measured: 12, 26, and 52 weeks

  9. Proportion of participants who reduced their AUDIT-C score category by by ≥ 1 risk level

    AUDIT-C = Alcohol Use Disorders Identification Test-Consumption.

    AUDIT-C scores range from 0 to 12 points, and are a sum of scores for each of its 3 questions. Lower scores indicate less alcohol use; higher scores indicate greater alcohol use. Unhealthy alcohol use in the U.S. is defined as a score greater than 4 for men, and a score greater than 3 for women.

    AUDIT-C scores can also be categorized into four risk levels: 0-4 indicates lower risk, 5-7 indicates increasing risk, 8-10 indicates higher risk, and 11 to 12 indicates possible dependence. An example of reducing by one risk level: a change from a score of 6, "increasing risk", at baseline to a score of 3, "lower risk", at follow-up.

    The number of individuals that reduce their AUDIT-C score category by at least one risk level will be divided by the total number of participants to obtain this outcome proportion.

    Measured: 12, 26, and 52 weeks

  10. Proportion of participants with an AUDIT score within the "lower risk" category

    AUDIT = Alcohol Use Disorders Identification Test (10-items, a tool developed by the World Health Organization to evaluate a person's use of alcohol).

    AUDIT scores range from 0 to 40 points. The score is a sum of scores for its 10 questions, each of which range from 0 to 4. Lower scores indicate less alcohol use; higher scores indicate greater alcohol use. Scores of 8 and greater are suggestive of an alcohol problem.

    AUDIT scores can also be categorized into four risk levels: 0-7 indicates lower risk, 8-15 indicates increasing risk, 16-19 indicates higher risk, and 20+ indicates possible dependence. An example of reducing by one risk level: a change from a score of 9, "increasing risk", at baseline to a score of 5, "lower risk", at follow-up.

    The number of individuals that have AUDIT scores of 7 or lower will be divided by the total number of participants to obtain this outcome proportion.

    Measured: 12, 26, and 52 weeks

  11. Proportion of participants who reduced their AUDIT score category by by ≥ 1 risk level

    AUDIT = Alcohol Use Disorders Identification Test (10-items, a tool developed by the World Health Organization to evaluate a person's use of alcohol).

    AUDIT scores range from 0 to 40 points. The score is a sum of scores for its 10 questions, each of which range from 0 to 4. Lower scores indicate less alcohol use; higher scores indicate greater alcohol use. Scores of 8 and greater are suggestive of an alcohol problem.

    AUDIT scores can also be categorized into four risk levels: 0-7 indicates lower risk, 8-15 indicates increasing risk, 16-19 indicates higher risk, and 20+ indicates possible dependence. An example of reducing by one risk level: a change from a score of 9, "increasing risk", at baseline to a score of 5, "lower risk", at follow-up.

    The number of individuals that reduce their AUDIT score category by at least one risk level will be divided by the total number of participants to obtain this outcome proportion.

    Measured: 12, 26, and 52 weeks

  12. Number of heavy drinking days

    Heavy drinking days are defined as days with ≥ 5 drinks for men and ≥ 4 drinks for women.

    Based on the timeline follow-back (TLFB) calendar method; 7-day follow-back for weeks 1-12 and 28-day follow-back for weeks 26 and 52.

    The number of heavy drinking days will be determined by counting the number of days of heavy drinking within each follow-back period.

    Measured: 1-12, 26, and 52 weeks

  13. Maximum number of drinks on any day over the timeline follow-back period

    Based on the timeline follow-back (TLFB) calendar method; 7-day follow-back for weeks 1-12 and 28-day follow-back for weeks 26 and 52.

    The maximum number of drinks will be determined over the 7-day follow-back periods for weeks 1-12, and the 28-day follow-back periods for weeks 26 and 52.

    Measured: 1-12, 26, and 52 weeks

  14. Proportion of days abstinent

    Based on the timeline follow-back (TLFB) calendar method; 7-day follow-back for weeks 1-12 and 28-day follow-back for weeks 26 and 52.

    Proportion of days abstinent will be calculated as number of days where 0 drinks were reported that day, out of the total number of days in that follow-back period (7 or 28).

    Measured: 1-12, 26, and 52 weeks

  15. Average duration of continuous abstinence

    Based on the timeline follow-back (TLFB) calendar method; 7-day follow-back for weeks 1-12 and 28-day follow-back for weeks 26 and 52.

    Calculated as the average number of consecutive days where 0 drinks were reported on the timeline follow-back.

    Measured: 12, 26, and 52 weeks

  16. Proportion of participants who reduced their World Health Organization (WHO) risk drinking level by ≥ 1 risk level

    The WHO risk drinking levels are defined as follows:

    low risk = 0 to 2.9 drinks/day (men) and 0 to 1.4 drinks/day (women) medium risk = 3.0 to 4.3 drinks/day (men) and 1.5 to 2.8 drinks/day (women) high risk = 4.4 to 7.1 drinks/day (men) and 2.9 to 4.3 drinks/day (women) very high risk = 7.2+ drinks/day (men) and 4.4+ drinks/day (women)

    Based on the average daily alcohol consumption which is reported as the mean number of standard drinks per day over the past 7-28 days, based on the timeline follow-back (TLFB) calendar method. Example of reducing one drinking level: a woman decreasing from an average of 3 drinks per day (high risk) to an average of 2 drinks per day (medium risk).

    The number of individuals that reduce their WHO risk drinking level by at least one level will be divided by the total number of participants to obtain this outcome proportion.

    Measured: 12, 26, and 52 weeks

  17. Adverse consequence related to alcohol

    Adverse consequence related to alcohol are assessed via the short inventory of problems revised (SIP-R), a15-item measure. The 15 items are rated on a 4-point scale (from 0-3); 0 = Never, 1 = Once or a few times, 2 = Once or twice a week, 3 = Daily or almost daily.

    Scores for the SIP-R range from 0 to 45, where a higher score indicates experience with greater adverse consequences related to alcohol.

    Measured: 12, 26, and 52 weeks

  18. Drinking motivations

    Drinking motivations are assessed via the Drinking Motivation Questionnaire Revised (DMQR, 20 items). The 20 items are rated on a 5-point Likert scale (from 1-5); 1 = Almost Never/Never, 2 = Some of the time, 3 = Half of the time, 4 = Most of the time, 5 = Almost Always/Always.

    This scale has 5 items each for reflecting the following four categories of motives: social, coping, enhancement, and external social pressures.

    The DMQR yields four scale scores (between 5 and 25) reflecting each of these motives for drinking alcohol, where a higher score indicates greater frequency of the reason motivating them to drink alcohol.

    Measured: 12, 26, and 52 weeks

  19. Desire to change drinking habits

    Participants are asked: "Do you have any desire to change your drinking habits?"

    With the following options to answer:

    • No, I'm comfortable with my current habits
    • No, I know I could drink a little less but I'm not motivated to change right now
    • Yes, I'm interested in drinking a little less
    • Yes, I'm interested in drinking a lot less
    • Yes, I'm interested in stopping drinking for a short period of time
    • Yes, I'm interested in stopping drinking for a long period of time

    Measured: Baseline

  20. Reasons for desired change in drinking habits

    Participants are asked: "What are your reasons for wanting to change your drinking?" The following options are provided (participants select all that apply): physical health/disease prevention or disease management, physical wellness/fitness, spend less money, diet/reduce calorie intake, mental health, mindfulness goals, relationship improvement, work/career improvement, or other (please describe).

    Participants are then asked to rank the selected options starting at 1 = Most important (ending at the number of reasons that were selected).

    Measured: Baseline

  21. Readiness to change

    Participants are asked: "How ready are you to make changes to your drinking habits?" Answered on a range from 1-10; 1 = not at all ready, 10 = extremely ready. A higher score indicates greater readiness to change drinking habits.

    Measured: 4 and 12 weeks

  22. Expected success to change drinking habits

    Participants are asked: "If you were to change your drinking habits now, how successful would you be?" Answered on a range from 1-10; 1 = not at all successful, 10 = extremely successful. A higher score indicates greater expected success in changing drinking habits.

    Measured: 4 and 12 weeks

  23. Expected difficulty maintaining reduction/abstinence

    Participants are asked: "If you were to change your drinking habits now, how difficult do you think it would be to keep your new habits?" Answered on a range from 1-10; 1 = not difficult at all, 10 = extremely difficult. A higher score indicates greater expected difficulty to change drinking habits.

    Measured: 4 and 12 weeks

  24. Satisfaction with current drinking behavior

    Participants are asked: "How satisfied are you with your current drinking behavior?" Answered on a range from 1-10; 1 = not at all satisfied, 10 = very satisfied. A higher score indicates greater satisfaction with current drinking behavior.

    Measured: 12, 26, and 52 weeks

  25. User feedback - set up and getting started with the program

    Assessed with the following question: "How easy or difficult was it to set-up and get started in the Pivot program?" Participants answer on a 1-10 scale; 1 = very difficult, 10 = very easy. A higher score indicates an easier time setting up and getting started with the program.

    Measured: 4 weeks

  26. User satisfaction - Net Promoter Score

    Specifically regarding likelihood to recommend to a friend or colleague, Net Promoter Score (NPS). Participants are asked: "How likely would you be to recommend the Pivot Clear program to a friend or colleague that had a desire to drink less?" Answered on a range from 1-10; 1 = not at all likely, 10 = very likely. A higher score indicates greater user satisfaction and promotion of the program.

    Measured: 4, 12, and 26 weeks

  27. User satisfaction - how use of the program has affected alcohol consumption

    Participants are asked: "How has using the Pivot program affected your alcohol consumption?"

    Participants are provided with the following options to choose from:

    • Using the program has increased my alcohol consumption
    • Using the program has not affected my alcohol consumption
    • Using the program has decreased my alcohol consumption

    Measured: 5 weeks

  28. User satisfaction - effectiveness of the program

    Participants are asked: "Did you find the Pivot Clear program effective so far?".

    Participants are provided 4 choices to answer: very effective, somewhat effective, not really effective, not at all effective

    Measured: 12 weeks

  29. User satisfaction - whether the program helped the participant maintain alcohol reduction

    Participants are presented with the following statement: "The program has helped me maintain a new drinking level where I drink less than when I started the study." Participants are asked to select True/False.

    Measured: 12, 26, and 52 weeks

  30. User satisfaction - program's ability to help someone reduce or quit alcohol

    Participants are asked: "Which of the following best describes the Pivot Clear program's ability to help someone reduce or quit alcohol?"

    Participants are provided the following options to choose from:

    • The program is extremely helpful
    • The program is helpful
    • The program does not affect being able to reduce or quit alcohol
    • The program makes reducing or quitting alcohol more difficult

    Measured: 10 weeks

  31. User satisfaction - perceived need for the program

    Participants are asked: "Which of the following best describes your need for the Pivot Clear program".

    Participants are provided the following options to choose from:

    • I really need this program
    • I somewhat need this program
    • I don't need this program
    • I am not at all interested in this program

    Measured: 4 weeks

  32. User satisfaction - effect of program on motivation to reduce/abstain

    Participants are asked: "How has using the Pivot program affected your motivation to change your drinking habits?"

    Participants are provided with the following options to choose from:

    • Using the program has increased my motivation to change my drinking habits
    • Using the program has not affected my motivation to change my drinking habits
    • Using the program has decreased my motivation to change my drinking habits

    Measured: 3 weeks

  33. User feedback - initial reactions to program design, specific program features including the breathalyzer, coaching, lessons, and drink tracking

    Participants are asked: "What best describes your initial reaction to finding out a [breathalyzer; coach; drink tracker] was a part of this program?"

    Participants are provided the following to choose from:

    • I thought it was out of place in the program as I think it is [a legal/compliance/negative tool for; a substance abuse counselor for; only used by] those with a severe drinking problem
    • I don't think it is necessary or helpful
    • I was curious about it and didn't have strong feelings
    • Made sense to me as this was a program related to [alcohol, behavior change, alcohol consumption behavior]
    • I was very interested to use it

    Measured: 1 week

  34. User feedback - program design, specific program features including the breathalyzer, coaching, lessons, and drink tracking

    Participants are asked various questions regarding program features and design.

    Participants are asked: "Have you gained any insights from your [initial use of the breathalyzer; initial interactions with the drink tracker in the Pivot app; initial interactions with the coach; interactions with the lessons]? Check all that apply."

    Participants are provided the following options to choose:

    • Not applicable
    • Not really
    • It confirmed what I already thought
    • It was motivating
    • It was demotivating
    • It triggered me to drink more
    • It triggered me to drink less

    Measured: 2, 3, 5, and 12 weeks

  35. User satisfaction - aspects of program participant enjoyed most/least

    Participants are asked: "What aspect of the program do you enjoy the most so far?" and "What aspect of the program do you enjoy the least so far?".

    For both questions they are provided the following to choose from:

    • Coaching
    • Tracker
    • Lessons
    • Breathalyzer
    • Other app contents/features (please specify)

    Measured: 12 weeks

  36. User feedback - possible future program features

    Participants are asked about potential future program features (small interest groups, breathalyzer connected to the app, text-based community, coaching via phone calls).

    They are provided the following to choose from:

    • Very interested
    • Somewhat interested
    • Probably not interested
    • Definitely not interested
    • Comments (optional)

    Measured: 12 weeks

  37. Use of other alcohol reduction or abstinence tools (apps, counseling, medications, etc.)

    Assessed via self-report. Participants are asked about other alcohol reduction or abstinence tools they have used throughout the last 6 months. Tools asked about include: apps (other than Pivot), counseling, medications, acupuncture, hypnotherapy, etc. Participants can report other tools not included in the list provided. Outcome reported as the number of participants who have used each other alcohol reduction or abstinence tools.

    Measured: 11, 26, and 52 weeks

  38. Engagement with the program - app openings

    Collected via back-end app data collection. Engagement is specifically assessed with number of times the Pivot app was opened (number of app openings), number of days the app was opened, and the number of weeks the app was opened. All are assessed over the first 26 weeks of study enrollment.

    Measured: 26 weeks

  39. Engagement with program - number of days with app openings

    Collected via back-end app data collection. Engagement is specifically assessed with the number of days over which the app was opened by participants over the first 26 weeks of study enrollment.

    Measured: 26 weeks

  40. Engagement with program - number of weeks with app openings

    Collected via back-end app data collection. Engagement is specifically assessed with the number of weeks over which the app was opened by participants over the first 26 weeks of study enrollment.

    Measured: 26 weeks

  41. Engagement with program - average duration of app sessions

    Collected via back-end app data collection. Engagement is specifically assessed with the average duration of app sessions completed by participants over the first 26 weeks of study enrollment. Outcome unit of measure = duration in minutes.

    Measured: 26 weeks

  42. Engagement with program - use of app features

    Collected via back-end app data collection. Engagement is specifically assessed with the use of app features (Lessons, Drink Logging, Crush a Craving, Challenges/Triggers, Goal Setting) by participants over the first 26 weeks of study enrollment. Reported as the number of times each app feature was used.

    Measured: 26 weeks

  43. Engagement with program - average number of messages

    Collected via back-end app data collection. Engagement is specifically assessed with average number of messages sent by coach to participant per week and average number of messages sent by participant to coach per week, over the first 26 weeks of study enrollment.

    Measured: 26 weeks

  44. Engagement with program - average number of weeks with coach engagement

    Collected via back-end app data collection. Specifically, the average number of weeks with at least one message sent from participant to coach over the first 26 weeks of study enrollment.

    Measured: 26 weeks

  45. Change in ratings of self-reported health indicators

    The following health indicators are assessed: sleep quality, nutrition/diet quality, weight management, ability to manage stress, physical fitness, mental health (anxiety, depression, bipolar as applicable), and chronic diseases (cardiovascular disease, diabetes, high blood pressure, asthma, COPD, acid reflux as applicable).

    COPD = chronic obstructive pulmonary disease

    Participants are asked to rate each of the above health indicators on a scale of 1-5; 1 = poor, 5 = excellent.

    Ratings at each timepoint are compared to the baseline score to determine their change.

    Measured: 12 and 26 weeks

  46. Average rating of positive change experienced in self-reported health indicators

    The following health indicators are assessed: sleep quality, nutrition/diet quality, weight management, ability to manage stress, physical fitness, mental health (anxiety, depression, bipolar as applicable), and chronic diseases (cardiovascular disease, diabetes, high blood pressure, asthma, COPD, acid reflux as applicable).

    Participants are asked to rate each based on if they experienced any positive change in that area due to reduced drinking; scale 1-5; 1 = not at all, 5 = very much. Greater scores on the scale indicate greater positive change experienced in that area of health.

    The ratings for each health indicator are averaged across participants to generate the average rating.

    Measured: 12 and 26 weeks

  47. Depressive symptoms

    Assessed via the Center of Epidemiological Studies Depression Scale (CES-D) screening questionnaire, 10 items. A score is calculated from a sum of the 10 items. Possible scores on the scale range from 0-30. Higher scores indicate greater severity of depressive symptoms, a worse outcome.

    Measured: 12, 26, and 52 weeks

  48. Anxiety

    Anxiety is assessed via Generalized Anxiety Disorder 7-item scale (GAD-7). The following is asked regarding the 7 items: "Over the last two weeks, how often have you been bothered by the following problems?". The 7 items are rated on a 4-point scale (from 0-3); 0 = Not at all, 1 = Several days, 2 = More than half the days, 3 = Nearly every day.

    Scores for the GAD-7 range from 0 to 21, where a higher score indicates greater severity of anxiety, a worse outcome. The following are score ranges and their associated anxiety severity: 0-4 minimal anxiety, 5-9 mild anxiety, 10-14 moderate anxiety, and 15-21 severe anxiety.

    Measured: 12, 26, and 52 weeks

  49. Resilience

    Resilience is assessed via The Brief Resilience Scale (6-item, self-report measure).

    The 6 items are rated on a 5-point scale (from 1-5); 1 = Strongly disagree, 2 = Disagree, 3 = Neutral, 4 = Agree, 5 = Strongly agree.

    Scores for the Brief Resilience Scale range are a result of adding the scores for the 6 items together and dividing that total by 6 (this is the average score for the items). Scores range from 1 to 5, where a higher score indicates greater resilience, a better outcome.

    Measured: 12, 26, and 52 weeks

  50. Well-being

    Well-being is assessed via the WHO-5 Well-being Index (5 items) score.

    The 5 items are rated on a 6-point scale (from 5-0); 5 = All of the time, 4 = Most of the time, 3 = More than half the time, 2 = Less than half the time, 1 = Some of the time, 0 = At no time.

    Scores for the WHO-5 Well-being Index result from adding the scores for the 5 items together. The score ranges from 0 to 25, where a higher score indicates greater well-being and quality of life, a better outcome.

    Measured: 12, 26, and 52 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 May 2024
  2. Study startJun 2024 (estimated)
  3. Primary completionJun 2025 (estimated)
  4. Study completionJun 2026 (estimated)

Why it stopped: Change in research priorities

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06401967
Sponsor's protocol ID
C-510
Status last verified
Jun 2024
First submitted
2 May 2024
Last updated
1 Jul 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes

Questions about this trial

What is this clinical trial studying?

A study testing Pivot Clear and BACtrack breathalyzer in people with Alcohol Use, Unspecified, run by Pivot Health Technologies Inc. at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 1 Jul 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Proportion of participants who complete all 12 weekly follow-up assessments (time frame: 12 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Jul 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in